Next Stop: Heidelberg! 🇩🇪


Heidelberg get ready! 😍

Leading national or international scientific institutions, world-renowned hospitals,
research-intensive and innovative enterprises, you can find it all in Heidelberg. Therefore, we decided to stay on our home turf, Germany, and head to Heidelberg for this one! So, you’re invited to join us and the rest of the biotech gang for a relaxed biotech meetup on the 31st of January. Beer is on us! 🤩🍻

Get ready to meet some great people, listen to some awesome speakers, and enjoy some free beer. You will be able to find us at Urban Kitchen looking super cool in our Labiotech t-shirts.

Thanks to BaseLaunch and BioRN for being such cool co-hosts and both NIBC and for supporting us 😉


Friedrich von Bohlen– CEO & Founder of Molecular Health.

He has been active in the Life Sciences since the beginning of his advanced education and he brings more than 20 years of entrepreneurial experience to the industry. Friedrich von Bohlen began his professional career in 1992 as a Project Manager in research & development at Fresenius AG, Bad Homburg, following which he was Assistant to the Chairman of the Supervisory Board of FAG Kugelfischer KGaA, Schweinfurt. He then served as CEO of Wasag Chemie AG, Essen. In 1997 he co-founded Lion Bioscience AG, Heidelberg (now Expedeon AG) which he served as CEO until 2004. Currently he is Chairman of the Supervisory Board of Apogenix AG and Novaliq GmbH as well as Board member of AC Immune SA, CureVac AG, immatics biotechnologies GmbH and Heidelberg Pharma AG.

Andreas Schmidt– Chief Executive Officer at Proteona

Using an artificial intelligence approach proteona sheds new light on the interaction of mRNA and proteins in thousands of cells in every clinical sample enabling new insights into immunoncology and making new immuncell therapies possible. Proteona is a spin off from the lab of Gene Yeo at the National University of Singapore / UC San Diego as well as the A-Star Molecular Engineering Lab of Nobel Laureate Sydney Brenner. Previously Andreas has co-founded AYOXXA Biosystems and headed the translational proteomics company as CEO from 2009 to 2016 continuously expanding the company to 40 employees operating from three sites in Cologne Germany, Singapore and Boston. He raised more than 25 Mil USD in venture capital, built the overall strategy of the company and established partnerships with several multinational pharma companies and leading academic institutions.

What to expect?

  • Relaxed biotech event
  • 2 fireside chats with awesome speakers
  • Networking opportunities with the biotechnologists in your area
  • 70 attendees
  • Free entry
  • Free beers and snacks
  • The unique Refresh vibe

Remember to leave your tie/blazers at home so you can chill out and be a biotech nerd in comfort.


Check out what happened in Basel:

What happens if I miss out on this Refresh?

See what we’re up to next by subscribing to our lovely newsletter 😊

If you have any questions then feel free to send me a message at

Support good journalism, subscribe to Labiotech Insider

Labiotech Insider

If you liked this post and want to read more good journalism, support us by joining Labiotech Insider. Our Insider membership gives you access to exclusive content and other advantages.